DAFTAR PUSTAKA
1. Park SJ, Shin JI. Complications of nephrotic syndrome. Korean J Pediatr.
2011;54(8):322-8.
2. Davin JC, Rutjes NW. Nephrotic syndrome: from bench to treatment. Int J Nephrol.
2011;1-6.
3. Noer MS. Sindrom nefrotik idiopatik. Dalam: Noer MS, Soemyarso NA, Subandiyah
K, Prasetyo RV, Alatas H, dkk, penyunting. Kompendium nefrologi anak. Jakarta:
UKK nefrologi IDAI; 2011.h.72-87.
4. Pais P, Avner ED. Nephrotic syndrome. Dalam: Kliegman RM, Stanton BF, St.Geme
JW, Schor NF, Behrman RE, penyunting. Nelson texbook of pediatrics. Edisi ke-19.
USA: Elsevier saunders; 2011.h.1801-7.
5. Valentini RP, Smoyer WE. Nephrotic syndrome. Dalam: Kher KK, Schnaper HW,
Makker SP, penyunting. Clinical pediatric nephrology. Edisi ke-2. USA: Informa
healthcare; 2007.h.155-94.
6. Mohammed SM, Elmazary A, Taha HT. Ankle brachial index in children with
steroid-resistant nephrotic syndrome. Sultan Qaboos University Med J. 2013;13(1):88-92.
7. Willenberg T, Diehm N, Zwahlen M, Kalka D, Do DD, dkk. Impact of Long-term
corticosteroid therapy on the distribution pattern of lower limb atherosclerosis. Eur J
Vasc Endovasc Surg. 2010;39:441-6.
8. Shammas NW. Epidemiology, classification, and modifiable risk factors of peripheral
arterial disease. Vascular health and risk management. 2007;3(2):229-34.
10. Papa EDE, Helber I, Ehrlichmann MR, Alves CMR, Makdisse M, Matos LN, dkk.
Ankle-brachial index as a predictor of coronary disease events in elderly patients
submitted to coronary angiography. Clinics. 2013;68(12):1481-7.
11. Eddy AA, Symons JM. Nephrotic syndrome in childhood. USA: Lancet. 2003;
362:629-39.
12. Sarker MN, Islam MMSU, Saad T, Shoma FN, Sharmin LS, Khan HA, dkk. Risk
factor for e in childhood nephrotic syndrome - a hospital based retrospective study.
Faridpur Med coll J. 2012;7(1):18-22.
13. Lawang SA, Rauf S, Lisal JS, Albar H, Daud D. Plasma lipids as risk factors in ing
nephrotic syndrome. Paediatr Indones. 2008;48(6):322-6.
14. Lum GM. Kidney and urinary tract. Dalam: Hay WW, Levin MJ, Sondheimer JM,
Deterding RR, penyunting. Current diagnosis and treatment pediatrics. Edisi ke-19.
USA: Lange; 2009.h.651-72.
15. Wirya IW. Sindrom nefrotik. Dalam: Alatas H, Tambunan T, Trihono PP, Pardede
SO, penyunting. Buku ajar nefrology anak. Edisi ke-12. Cetakan ke-4. Jakarta:
Badan penerbit IDAI; 2002.h.381-426.
16. Hogg RJ, Portman RJ, Milliner D, Lemley KV, Eddy A, dkk. Evaluation and
management of proteinuria and nephrotic syndrome in children: Recomendation
from pediatric nephrology panel established at the national kidney foundation
conference on proteinuria, albuminuria, risk, assessement, detection, and
elimination (PARADE). American Academy of Pediatrics. 2000; 105:1242-9 Diunduh
17. Seigneux S, Martin PY. Management of patients with nephrotic syndrome. Swiss
Med Wkly. 2009;139(29-30):416-22.
18. Roth KS, Amaker BH, Chan JCM. Nephrotic syndrome: pathogenesis and
management. Diunduh dari at
Indonesia: AAP. Diakses pada tanggal 10 Januari 2015.
19. Hirsch AT, Criqui MH, Treat-Jacobson D, Regensteiner JG, Greager MA, Olin JW,
dkk. Peripheral arterial disease detection, awareness, and treatment in primary care.
JAMA. 2001;286(11):1317-24.
20. Bendermacher BLW, Teijink JAW, Willigendael EM, Bartelink ML, Buller HR, Peters
RJG, dkk. Symptomatic peripheral arterial disease: the value of a validated
questionnaire and a clinical decision rule. Br J of Genera Pract. 2006;56:932-44.
21. Hong YM. Atherosclerosis cardiovascular disease begining in chilhood. Kcj.
2010;40(1):1-9.
22. Garcia LA. Epidemiology and pathofisiology of lower extremity peripheral arterial
disease. J Endovasc Ther. 2006;13(Suppl II):II-3-II-9.
23. Aronow WS. Peripheral arterial diseaseof the lower extremities. Arc Med Sci.
2012;8(2):375-88.
24. Khan NA, Rahim SA, Anand SS, Simel DL, Panju A. Does the clinical examination
predict lower extremity peripheral arterial disease? JAMA. 2006;295(5):536-46.
25. Criqui MH, Langer RD, Fronek A, Feigelson HR, Klauber MR, McCann TJ, dkk.
Mortality over a period of 10 years in patients with peripheral disease. N Engl J
26. Hertzer NR, Beven EG, Young JR, O’hara PJ, Ruschhaupt II WF, dkk. Coronary
artery disease in peripheral vascular patients. Ann. Surg; 1984.h.223-33.
27. Ouriel K. Peripheral arterial disease. Lancet. 2001;358:1257-64.
28. Khan TH, Farooqui FA, Niazi K. Critical review of the ankle brachial index. Current
Cardiology Review. 2008;4:101-6.
29. McDermont MM, Criqui MH, Liu K, Guralnik JM, Greenland P, Martin GJ, dkk. Lower
ankle/brachial index, as calculated by averaging the dorsalis pedis and posterior
tibial pressures, and association with leg functioning in peripheral arterial disease. J
Vasc Surg . 2000;32(6):1164-71.
30. Ostomy W, Society CN. Ankle brachial index quick reference guide for clinicians. J
Wound Ostomy continence Nurs. 2012;39(2S):S21-S9.
31. Grenon SM, Gagnon J, Hsiang Y. Ankle-brachial index for assessment of peripheral
arterial disease. N Engl J Med. 2009;361(e40):1-3.
32. Pathil AB, Kodliwadmath MV, Sonoli S. Corelation of serum cholesterol level with
urinary protein loss in nephrotic syndrome. International Journal of Medocobiological
Research. 2011;1:137-9.
33. Mark DB, Marks AD, Smith CM, editor. Biokimia kedokteran dasar Jakarta: Penerbit
buku kedokteran; 2008.
34. Gbadegesin R, Smoyer WE.Nephrotic syndrome. Dalam: Geary DF, Schaefer F.
penyunting. Comprehensive pediatric nephrology. Philadelphia; 2008.
35. National cholesterol education program (NCEP) : Higlights of the report the expert
36. Thabet MAEH, Salcedo JR, Chan JCM. Hyperlipidemia in childhood nephrotic
syndrome. Pediatr Nephrol. 1993;7:559-66.
37. Vinuesa SG, Ortega M, Martinez P, Goicoechea M, Campdera FG, Luno J.
Subclinical peripheral arterial disease in patients with chronic kidney disease:
Prevalence and related risk factors. Kidney Int. 2005;67(93):S44-7.
38. Fahal IH, McClelland, Hay CRM, Bell GM. Arterial thrombosis in the nephrotic
syndrome. Postgrad Med J. 1994;70:905-9.
39. Toussaint ND, Kerr PG. Vascular calcification and arterial stiffness in chronic kidney
disease: Implication and management. Nephrol. 2007;12:500-9.
40. Maxwell SRJ, Moots RJ, Kendall MJ. Corticosteroids: do they damage the
cardiovascular system? Postgrad Med J. 1994;70:863-70.
41. Singhal R, Brimble KS. Thromboembolic complications in the nephrotic syndrome:
Pathophysiology and clinical management. Thrombosis Research.
2006;118:397-407.
42. Dahlan S, Menggunakan rumus besar sampel secara benar. Dalam: Dahlan S,
penyunting. Besar sampel dan cara pengambilan sampel dalam penelitian
kedokteran dan kesehatan. Jakarta: Sagung Seto; 2013.h.35-80.
43. Wass VJ, Chilvers C, Jarret RJ, Cameron JS. Does the nephrotic syndrome
increase the risk of cardiovaskular disease?. Lancet. 2008:664- 67.
44. Kari JA, Tashkandi M, Medhat AM, Khoja SO, Ramadan KS. Lipoprotein (a) and
other dyslipidemia in Saudi children with nephrotic syndrome (SSNS and SRNS).
45. Chang J, Tsai H, Yang L, Chen T. Epidemiology and predictors of end-stage renal
disease in Taiwanese children with idiopathic nephrotic syndrome. J Epidemiol.
2012;22:517-22.
46. Vowden P, Vowden K. Doppler assessment and ABPI: Interpretation in the
management of leg ulceration. From:
47. Yao ST, Hobbs JT, Irvine WT. Ankle systolic pressure measurements in arterial
disease affecting the lower extremities. Br J Surg. 1969;56:676-9.
48. Ouriel K, McDonnell AE, Metz CE, Zarins CK. Critical evaluation of stress testing in
the diagnosis of peripheral vascular disease. Surgery. 1982;91:686-93.
49. Zilleruelo G, Hsia SL, Freundlich M, Gorman HM, Strauss J. Persistence of serum
lipid abnormalities in children with idiopathic nephrotic syndrome. J Pediatr.
1984;104:61-4.
50. Appel GB, Blum CB, Chien S, Kunis CL, Appel AS. The hyperlipidemia of the
nephrotic syndrome. Relation to plasma albumin concentration, oncotic pressure,
and viscosity. N Engl J Med. 1985;312:1544-8.
51. Strauss J, Zilleruelo G, Freundlich M, Abitbol C. Less commonly recognized features
